4th Quarter - Report

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
—
Expenses
$1,090,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Tax issues, including economic stimulus legislation, and bilateral US-UK tax issues

LobbyistCovered position, as disclosed
KENNETH LEVINSON Leg. Assistant to Sen. Jay Rockefeller 1991-97

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Treasury, Dept of

Copyright/Patent/Trademark CPT

S.1145-The Patent Reform Act of 2007, Potential implications of pharmaceutical patent protection, including reform to address current inefficiencis that do not harm innovative industries-US Senate Patent settlements (reverse payments) legislation-US House/US Senate Regarding intellectual property issues

LobbyistCovered position, as disclosed
RICHARD BUCKLEY —
KENNETH LEVINSON Leg. Assistant to Sen. Jay rockefeller 1991-97
BRADLEY ALLEN ROSSIN —

Contacted: Health & Human Services, Dept of (HHS); Treasury, Dept of; SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: S. 1145 (110th)

Health Issues HCR

S.558-The Mental Health Parity Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Health Care Reform:S.334-The Healthy Americans Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Cancer access and affordability issues, generally. No active legislation. Provision of information regarding company patient assistance programs. No active legislation. HIT 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Grassley/Kohn Physician Payments Sunshine Act Minority Outreach - Congressional Hispanic Caucus. No active legislation.

LobbyistCovered position, as disclosed
CHRISTINE BLOOMQUIST New —
RICHARD BUCKLEY —
MICHAEL DRAINE —
ANDRES IZQUIERDO —
AMANDA GRASHOF MOTT —
RICHARD WAYNE OLSON —
WAYNE PALMER —

Contacted: Treasury, Dept of; SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: H.R. 1424 (110th), S. 558 (110th), S. 334 (110th)

Trade (domestic/foreign) TRD

International trade issues, including free-trade agreements, with Members and Staff-US House/US Senate Import Safety - internal discussions

LobbyistCovered position, as disclosed
KENNETH LEVINSON Leg. Assistant to Sen. Jay Rockefeller 1991-97

Contacted: SENATE; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Treasury, Dept of

Medicare/Medicaid MMM

Medcaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act S.3118-The Preserving Access to Medicare Act Waxman proposal for Medicaid-type rebates for dual elibigles enrolled in Medicare Part D. No active legislation-US House Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D Anti-Preemption Medicare Part D-US House

LobbyistCovered position, as disclosed
RICHARD BUCKLEY —
AMANDA GRASHOF MOTT —
RICHARD WAYNE OLSON —
BRADLEY ALLEN ROSSIN —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Treasury, Dept of; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 6331 (110th), S. 3118 (110th), S. 3101 (110th)

Consumer Issues/Safety/Products CSP

Import Safety Discussion Draft Legislation-US House/US Senate FDA Import Safety/FDA Globalization Act Discussions regarding protection of patient safety from the commercial importation of prescription medications HR 5839-The Safeguarding America's Pharmaceuticals Act-US House Discussions regarding impact and safety issues surrounding the presence of pharmaceuticals in the environment. No specific legislation.

LobbyistCovered position, as disclosed
RICHARD BUCKLEY —
MICHAEL DRAINE —
BRADLEY ALLEN ROSSIN —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Treasury, Dept of; U.S. Trade Representative (USTR)

Bills named: H.R. 5839 (110th)

Pharmacy PHA

Regarding e-Prescribing Regarding implementation of PDUFA IV/FDAAA Direct-to-Consumer Advertisement User Fee Program

LobbyistCovered position, as disclosed
RICHARD WAYNE OLSON —
WAYNE PALMER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Treasury, Dept of

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.